SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-223118
Filing Date
2015-06-15
Accepted
2015-06-15 14:15:00
Documents
15
Period of Report
2015-07-15
Effectiveness Date
2015-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d935532ddef14a.htm DEF 14A 337264
2 GRAPHIC g935532g03o24.jpg GRAPHIC 5260
3 GRAPHIC g935532g21h01.jpg GRAPHIC 4473
4 GRAPHIC g935532g22s86.jpg GRAPHIC 4187
5 GRAPHIC g935532g23m58.jpg GRAPHIC 4840
6 GRAPHIC g935532g28v10.jpg GRAPHIC 5236
7 GRAPHIC g935532g30n77.jpg GRAPHIC 4085
8 GRAPHIC g935532g46j95.jpg GRAPHIC 24731
9 GRAPHIC g935532g49g70.jpg GRAPHIC 4933
10 GRAPHIC g935532g53t05.jpg GRAPHIC 4589
11 GRAPHIC g935532g58q33.jpg GRAPHIC 5584
12 GRAPHIC g935532g59e55.jpg GRAPHIC 6477
13 GRAPHIC g935532g59j17.jpg GRAPHIC 4876
14 GRAPHIC g935532g71a60.jpg GRAPHIC 6245
15 GRAPHIC g935532g99y91.jpg GRAPHIC 4490
  Complete submission text file 0001193125-15-223118.txt   464411
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36177 | Film No.: 15930902
SIC: 2834 Pharmaceutical Preparations